BACKGROUND: Noneosinophilic asthma is common across asthma severities. However, in patients with moderate-to-severe disease, the absence of sputum eosinophilia cannot distinguish between asthmatic subjects with eosinophilic inflammation controlled by corticosteroids versus those in whom eosinophilic inflammation is not a component of the disease. OBJECTIVES: We sought to develop a method to quantify eosinophil proteins in airway macrophages as a novel biomarker of eosinophilic airway inflamma...Expand abstract
- Publisher copy:
- Copyright date:
Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record